Apart from acute inflammation, chronic inflammation is often unnoticed or overlooked as the symptoms are usually subtle and painless. However chronic inflammation diseases, including heart disease, autoimmune diseases, cancer, obesity, and diabetes, contribute to over 50% of all deaths.
Prioritizing preventative health management is essential for improving healthcare outcomes. Without it, healthcare may miss opportunities for timely intervention, potentially resulting in less favorable prognosis. With continuous monitoring and earlier diagnosis, treatments can not only be more effective but also more cost-efficient.
Our team presents VigilaGuard, a rapid-reaction bio-device. VigilaGuard can detect inflammatory biomarkers with engineered bacteria. When it detects abnormal levels of inflammatory biomarkers, it will send a notification to our mobile app which can give our customers personalized health insights.
Our device, VigilaGuard, can not only recognize inflammation but also further supply hesperetin, which is an antioxidant that helps relieve inflammation. Hesperetin has been extensively studied for its biological and pharmacological properties. Aside from its antioxidant and anti-inflammatory properties, it has been found to have anticancer and antiviral effects and can provide protection against cardiovascular disorders and neurodegenerative conditions.
With the changing population demographics, we are entering a new era of healthcare where there is a rising need for preventative health management, including early diagnosis and remote monitoring for optimized healthcare. VigilaGuard offers customers an accessible chance to receive on-site health checks for inflammation. It also delivers timely and accurate wellness reports on our user-friendly mobile app, where customers can also receive personalized health insights.
© 2023 - Content on this site is licensed under a Creative Commons Attribution 4.0 International license.
The repository used to create this website is available at gitlab.igem.org/2023/nycu-taipei.